Columbus McKinnon Corporation CMCO
Revenue accelerating Order intake Margin compressing Guidance raised
The new quarter, monitored by AI. · We follow every stock through its original filings: the latest figures against their history, guidance against actuals; neutral, continuously updated, every figure clickable with its source.
AI-generated report · not investment advice · figures extracted automatically; please verify against the linked original more
AI-generatedCreated with AI assistance from the company's linked original filings (transparency per Art. 50 EU AI Act). More about the tool: Claude Code.
Not investment adviceNeutral financial information, no recommendation, no investment research within the meaning of MiFID II.
Verify yourselfFigures are extracted automatically, errors are possible. Every figure is clickable with its source; the issuer's original documents are always authoritative.
EditorialThe texts (business model, current status, development and others) are written AI-editorially from the original reports alone, cross-checked automatically and backed with sources; the company's own account, no assessment of our own. Methodology
AI research · This page works as a source-backed data basis for further research with AI assistants such as Claude; every figure remains verifiable via the source links.
Advertisement
Business Model#
What the company does and how it earns its money; written AI-editorially, exclusively from the company's original reports, without any assessment of our own.
Columbus McKinnon designs and manufactures hoists, rigging hardware, below-the-hook lifting devices, and precision conveyance systems used in material handling, lifting, and motion control applications. The company serves industrial end markets including manufacturing, construction, energy, entertainment, and government, generating revenue primarily through the capital equipment sale of powered and manual hoist systems, chain and wire rope assemblies, and related attachments. Following the $2.81 billion acquisition of Kito Crosby, completed February 3, 2026, Columbus McKinnon substantially expanded its scale and global reach, with the combined business targeting annual net sales above $2 billion and approximately 45% of revenue derived from customers outside the United States. The enlarged portfolio spans the Kito, Crosby, CM, Yale, Duff-Norton, and montratec brand families, competing across a broad range of lifting capacity classes and precision conveyance segments.
Advertisement
Current Status#
Summary of the most recent reporting period: core figures, drivers and management statements; written editorially from the current original report, every figure backed by a source number.
Columbus McKinnon reported net sales of $531.5 million for Q1 FY2027, a 125.3% increase year-over-year driven primarily by the $304.8 million revenue contribution from the Kito Crosby acquisition closed February 3, 2026, alongside $16.1 million in favorable volumes and $2.4 million in foreign currency tailwinds 32. Orders grew 120% to $568.1 million with a book-to-bill ratio of 1.1x, reflecting strong U.S. short-cycle demand, and adjusted EPS grew 22% to $0.61 33. Adjusted EBITDA reached $111.5 million at a margin of 21.0%, representing 720 basis points of expansion year-over-year, benefiting from Kito Crosby accretion and synergy realization 33. The company raised its full-year FY2027 guidance across net sales, adjusted EBITDA, and adjusted EPS, and confirmed the Kito Crosby integration remains on track 33.
Management commentary on the 2027-Q1 results (8-K-EX99.1, 2026-07-30):
„Our team delivered solid results in our first full quarter as a combined company, while also continuing to progress the integration and realize synergies. I am pleased with the strong start to the year, including substantial orders growth supported by robust U.S. short-cycle demand, increasing our confidence in the year ahead.“ – David J. Wilson, President and Chief Executive Officer 33
„Disciplined execution in the first quarter led to significant margin expansion, which included the accretive impact of the Kito Crosby Acquisition, synergy realization and benefits to material costs that were specific to the quarter. I remain confident in our ability to create shareholder value as we drive organic growth, improve margins, deliver free cash flow, and de-lever the balance sheet.“ – David J. Wilson, President and Chief Executive Officer 33
Revenue · 2027-Q1532$m+125.3 % vs. 2026-Q1
Net profit · 2027-Q1-88$m−4,552.6 % vs. 2026-Q1
EPS · 2027-Q1-2.05$−2,828.6 % vs. 2026-Q1
Revenue trend
Guidance
For FY2028, the company guides Net Leverage Ratio to below 4.0x (initiated). 29.
ProfitabilityOperating income was -$17.7 million and net income was -$88.4 million, yielding diluted EPS of -$2.05; results were impacted by a $200 million goodwill impairment charge in the Precision Conveyance reporting unit and acquisition-related costs 33. On an adjusted basis, net income was $30.5 million, with adjusted net income growing 114% year-over-year 33. Operating cash flow was $25.6 million against capital expenditures of $5.7 million, producing free cash flow of $20.0 million; non-cash adjustments of $63.8 million including $53.2 million of depreciation and amortization supported cash generation despite the reported net loss 32 133.
LeverageNet debt stood at $2,432.4 million at quarter-end against a cash balance of $98.4 million 133. The credit agreement net leverage ratio improved to 4.9x from 5.1x in the prior quarter, with management focused on continued debt reduction 33. Interest and debt expense surged to $47.6 million from $8.7 million in Q1 FY2026, reflecting the borrowings raised to finance the $2.81 billion Kito Crosby acquisition 32.
Management viewColumbus McKinnon raised full-year FY2027 guidance: net sales to $2.09-$2.15 billion (from $2.05-$2.12 billion), adjusted EBITDA to $405-$420 million (from $390-$410 million), and adjusted EPS to $1.90-$2.10 (from $1.70-$1.90) 33. Capital expenditure guidance for FY2027 was initiated at $50-$60 million, inclusive of the Kito Crosby business 32. Kito Crosby integration remained on track with synergy capture progressing as expected 33.
ChangeGross profit margin declined to 27.5% from 32.7% year-over-year, primarily due to $55.2 million of inventory step-up amortization from the Kito Crosby acquisition, partially offset by price increases and volume benefits 32. The divestiture of U.S. power chain hoist and chain manufacturing operations reduced net sales by $34.8 million relative to the prior-year period 32. The income tax rate moved to (31)% from (16)%, with the company estimating that valuation allowances on interest expense carryforwards will unfavorably impact the full-year FY2027 effective tax rate by 40-50% 32.
Risks (current)Columbus McKinnon carries net debt of $2,432.4 million; although the credit agreement net leverage ratio improved to 4.9x, sustained deleveraging is required 33. Approximately 45% of revenue originates from customers outside the United States, creating ongoing exposure to foreign exchange translation risk, and rising raw material costs and tariffs may not be fully offset by pricing actions 32. The company faces asbestos-related litigation for which management believes additional costs will not be material to financial condition, though future liabilities could be material to earnings; a $3.0 million product liability jury verdict from April 2024 was reversed on appeal in April 2026 and remanded for dismissal 31.
New this reporting periodThe Kito Crosby acquisition closed February 3, 2026, combining Kito Corporation and Crosby Group with Columbus McKinnon in a $2.81 billion transaction that materially increased the company's scale, product portfolio, and global footprint 32. The divestiture of U.S. power chain hoist and chain manufacturing operations was completed March 4, 2026, removing a product line that had contributed approximately $34.8 million to the prior-year comparable period 33.
Advertisement
Price & Chart#
Interactive price chart (TradingView) and the trend of key figures from the core tables. The price chart loads only after a click; at that point a connection to TradingView is established.
Daily candles with news and earnings markers. Loads only on click.
Advertisement · affiliate links; we may earn a commissionAffiliate partnerships help us keep these reports free and regularly updated.
Advertisement
Share-Price Drivers#
Factors the company itself names as material for its business development (IR-based); reproduced neutrally, no price forecast and no assessment of our own.
Kito Crosby Limited acquisition and its financing
The announced acquisition of Kito Crosby (2025-02-10) is transformative in scale: consolidated revenue rose to 531.5 in 2027-Q1 versus a 235–261 quarterly range in FY2026, while net debt expanded to 2,432.4 from 455.0, funded partly through a Series A convertible participating preferred share issuance 33 23 31 133
The announced acquisition of Kito Crosby (2025-02-10) is transformative in scale: consolidated revenue rose to 531.5 in 2027-Q1 versus a 235–261 quarterly range in FY2026, while net debt expanded to 2,432.4 from 455.0, funded partly through a Series A convertible participating preferred share issuance 33 23 31 133
Kito Crosby acquisition integration
Planned combination (announced 2025-02-10, expected late 2025) drove consolidated revenue to 531.5 in 2027-Q1, up sharply from the FY2026 quarterly range 33 23 133
Planned combination (announced 2025-02-10, expected late 2025) drove consolidated revenue to 531.5 in 2027-Q1, up sharply from the FY2026 quarterly range 33 23 133
Acquisition-related leverage
Net debt climbed to 2,432.4 in 2027-Q1 (2,462.1 in 2026-Q4) versus 455.0 in 2025-Q4, reflecting financing tied to the transaction and the preferred share issuance 133 130 31
Net debt climbed to 2,432.4 in 2027-Q1 (2,462.1 in 2026-Q4) versus 455.0 in 2025-Q4, reflecting financing tied to the transaction and the preferred share issuance 133 130 31
Divestiture of U.S. power chain hoist and chain operations
Sale of the U.S. power chain hoist and chain manufacturing operations to Star Hoist (2026-03-04) removed a product line from the portfolio 33 31 29
Sale of the U.S. power chain hoist and chain manufacturing operations to Star Hoist (2026-03-04) removed a product line from the portfolio 33 31 29
Reported vs. adjusted profitability gap
GAAP results turned to large losses (net income -88.4 in 2027-Q1, -238.1 in 2026-Q4) while adjusted EPS stayed positive (0.61, 0.24), with operating income negative on a reported basis 133 130
GAAP results turned to large losses (net income -88.4 in 2027-Q1, -238.1 in 2026-Q4) while adjusted EPS stayed positive (0.61, 0.24), with operating income negative on a reported basis 133 130
Manufacturing footprint consolidation
Relocation of North American Linear Motion operations to Monterrey, Mexico and the Precision Conveyance/Charlotte closures continued the footprint restructuring 14 18 21
Relocation of North American Linear Motion operations to Monterrey, Mexico and the Precision Conveyance/Charlotte closures continued the footprint restructuring 14 18 21
montratec automation exposure
The montratec acquisition (2023-05-31) remains active in the portfolio through 2027-Q1 32 31
The montratec acquisition (2023-05-31) remains active in the portfolio through 2027-Q1 32 31
Sector trend: Change flags point to accelerating growth, improving profitability and raised guidance, and adjusted operating income strengthened across FY2026 quarters (18.5 to 24.5) even as reported operating income turned negative under acquisition- and impairment-related charges 129 124 133. Material-handling demand and the enlarged post-acquisition revenue base are the dominant drivers of the KPI trajectory 23 133
Advertisement
Event Timeline#
This timeline collects the material events from the original reports: guidance changes, revenue and margin signals, strategy shifts, product and M&A announcements. Events are grouped by quarter (most recent first); the grey tag before each event names the event type, the date is the publication date of the source. Management quotes open the quarter block as direct quotes. Per quarter we show the three most defining events; more can be expanded per quarter, older years are collapsed. Every event carries its source as a superscript, clickable number.
Overview: one dot per event · click jumps to the period
2027 · 4 events
2027-Q1 · Apr – Jun 2026
„Our team delivered solid results in our first full quarter as a combined company, while also continuing to progress the integration and realize synergies. I am pleased with the strong start to the year, including substantial orders growth supported by robust U.S. short-cycle demand, increasing our confidence in the year ahead.“ – David J. Wilson, President and Chief Executive Officer 33
Revenue accelerating 2026-07-30
Net sales increased 125.3% to $531.5 million, driven primarily by $304.8 million contribution from the Kito Crosby acquisition closed February 3, 2026, partially offset by $34.8 million divestiture impact (32).
Net sales increased 125.3% to $531.5 million, driven primarily by $304.8 million contribution from the Kito Crosby acquisition closed February 3, 2026, partially offset by $34.8 million divestiture impact (32).
Margin compressing 2026-07-30
GAAP gross profit margin declined to 27.5% from 32.7%, reflecting $55.2 million inventory step-up amortization expense from Kito Crosby acquisition accounting (32).
GAAP gross profit margin declined to 27.5% from 32.7%, reflecting $55.2 million inventory step-up amortization expense from Kito Crosby acquisition accounting (32).
Guidance raised 2026-07-30
Full-year FY2027 guidance raised: net sales to $2.09-$2.15 billion (from $2.05-$2.12 billion), adjusted EBITDA to $405-$420 million (from $390-$410 million), adjusted EPS to $1.90-$2.10 (from $1.70-$1.90) (33).
Full-year FY2027 guidance raised: net sales to $2.09-$2.15 billion (from $2.05-$2.12 billion), adjusted EBITDA to $405-$420 million (from $390-$410 million), adjusted EPS to $1.90-$2.10 (from $1.70-$1.90) (33).
2026 · 15 events
2026-Q4 · Jan – Mar 2026
„While our fourth quarter performance was impacted amid a challenging macroeconomic and geopolitical environment, we enter fiscal 2027 with momentum and multiple avenues for growth and margin expansion. As we look ahead, we are encouraged by our growth and margin expansion prospects for Fiscal Year 2027, supported by encouraging demand trends, continued operational improvement and the benefits of our integration and portfolio actions. We remain focused on driving profitable growth, advancing our strategy, accelerating debt repayment and delivering compelling returns for our shareholders.“ – David J. Wilson, President and Chief Executive Officer 30
Net income turned negative 2026-06-08
FY2026 net loss of $229.5 million primarily driven by $200.0 million non-cash goodwill impairment for Precision Conveyance reporting unit and $36.8 million inventory step-up amortization from Kito Crosby, partially offset by $103.3 million gain on divestiture 31
FY2026 net loss of $229.5 million primarily driven by $200.0 million non-cash goodwill impairment for Precision Conveyance reporting unit and $36.8 million inventory step-up amortization from Kito Crosby, partially offset by $103.3 million gain on divestiture 31
Guidance initiated 2026-06-04
FY2027 guidance initiated: net sales $2.05–$2.12 billion, adjusted EBITDA $390–$410 million, adjusted EPS $1.70–$1.90 30
FY2027 guidance initiated: net sales $2.05–$2.12 billion, adjusted EBITDA $390–$410 million, adjusted EPS $1.70–$1.90 30
2026-Q3 · Oct – Dec 2025
„Having now closed on the acquisition of Kito Crosby, we are well positioned to deliver for our customers and shareholders as we begin executing on value creation initiatives.“ – David J. Wilson, President and Chief Executive Officer 29
Revenue accelerating 2026-02-09
Net sales increased 10.5% to $258.7 million driven by $11.7 million volume growth, $6.1 million pricing, and $6.7 million favorable currency translation 28 29
Net sales increased 10.5% to $258.7 million driven by $11.7 million volume growth, $6.1 million pricing, and $6.7 million favorable currency translation 28 29
Guidance cut 2026-02-09
Company withdrew standalone FY2026 guidance due to uncertainty from the pending U.S. power chain hoist divestiture and Kito Crosby integration 29
Company withdrew standalone FY2026 guidance due to uncertainty from the pending U.S. power chain hoist divestiture and Kito Crosby integration 29
2026-Q2 · Jul – Sep 2025
„Our team delivered a solid second quarter as the U.S. short-cycle market recovered and we executed on our record backlog. Our funnel of quotation activity remains healthy, driven by attractive global opportunities and an improving demand environment in the United States. While the funnel of activity in EMEA remains attractive, order conversion rates there have slowed recently given a weaker macroeconomic sentiment.“ – David J. Wilson, President and Chief Executive Officer 26
Revenue accelerating 2025-10-30
Net sales increased 7.7% to $261.0 million, driven by volume growth across all platforms with particular strength in lifting and linear motion, price increases, and favorable currency translation 25 26
Net sales increased 7.7% to $261.0 million, driven by volume growth across all platforms with particular strength in lifting and linear motion, price increases, and favorable currency translation 25 26
Margin expanding 2025-10-30
Gross margin expanded to 34.5% from 30.9% in Q2 FY2025, benefiting from higher sales volume, favorable mix, and factory consolidation benefits 25
Gross margin expanded to 34.5% from 30.9% in Q2 FY2025, benefiting from higher sales volume, favorable mix, and factory consolidation benefits 25
Acquisition 2025-10-30
Kito Crosby acquisition incurred $10.0 million in pre-tax integration costs in Q2 FY2026; closing expected by end of fiscal 2026 26
Kito Crosby acquisition incurred $10.0 million in pre-tax integration costs in Q2 FY2026; closing expected by end of fiscal 2026 26
Net income turned positive 2025-10-30
Net income turned positive for the first time after 2 negative periods (-1.9 to +4.6 USDm). 25
Net income turned positive for the first time after 2 negative periods (-1.9 to +4.6 USDm). 25
2026-Q1 · Apr – Jun 2025
„We continue to progress towards the closing of the Kito Crosby acquisition and believe with the benefits of scale, improved solutions, the realization of synergies and strong free cash flow, we will be positioned to grow profitably and deliver long-term value for our shareholders.“ – David J. Wilson, President and Chief Executive Officer 24
Margin compressing 2025-07-30
Gross margin declined to 32.7% from 37.1% in Q1 FY2025, driven by $5.7 million in material inflation and manufacturing cost changes and $4.2 million tariff impact 23 24
Gross margin declined to 32.7% from 37.1% in Q1 FY2025, driven by $5.7 million in material inflation and manufacturing cost changes and $4.2 million tariff impact 23 24
Guidance confirmed 2025-07-30
Company reaffirmed FY2026 guidance for flat to slightly up net sales and Adjusted EPS despite $0.11 per share unfavorable tariff impact in the quarter 24
Company reaffirmed FY2026 guidance for flat to slightly up net sales and Adjusted EPS despite $0.11 per share unfavorable tariff impact in the quarter 24
Acquisition 2025-07-30
Definitive agreement (signed February 10, 2025) to acquire Kito Crosby Limited for $2.7 billion in cash pending regulatory approval; G&A expenses increased $8.1 million from acquisition-related costs in Q1 FY2026 23
Definitive agreement (signed February 10, 2025) to acquire Kito Crosby Limited for $2.7 billion in cash pending regulatory approval; G&A expenses increased $8.1 million from acquisition-related costs in Q1 FY2026 23
Operating income halved 2025-07-30
Operating income more than halved YoY (21.1 to 5.5 USDm, -74%). 23
Operating income more than halved YoY (21.1 to 5.5 USDm, -74%). 23
2025 · 13 events
2025-Q4 · Jan – Mar 2025
„We enter fiscal 2026 with a strong backlog and continued order growth as our commercial initiatives gain traction. Our conviction in Columbus McKinnon's strategy and business model remains strong as we continue to anticipate tailwinds from industry megatrends like on-shoring, scarcity of labor and global infrastructure investments over time. We have a strong track record of navigating through uncertain environments and managing performance through volatility. Accordingly, we are actively working to mitigate the impact of tariff policies with supply chain adjustments, surcharges and price. I want to thank our Columbus McKinnon team for their relentless efforts to continuously improve customer service and advance our strategic initiatives as we execute on fiscal 2026 and work toward the closing of the Kito Crosby acquisition.“ – David Wilson, President and Chief Executive Officer 22
Net income turned negative 2025-05-28
Full-year net loss of $5.1M driven by $22.1M non-cash pension settlement costs, $16.4M factory consolidation costs, $12.8M Monterrey startup costs, and $10.3M acquisition-related costs, versus net income in fiscal 2024 22
Full-year net loss of $5.1M driven by $22.1M non-cash pension settlement costs, $16.4M factory consolidation costs, $12.8M Monterrey startup costs, and $10.3M acquisition-related costs, versus net income in fiscal 2024 22
revenue 2025-05-28
Record FY2025 orders of $1.0 billion, up 3%, with precision conveyance orders +19% and project-related business +8%; backlog +15% to $322.5M at March 31, 2025 22
Record FY2025 orders of $1.0 billion, up 3%, with precision conveyance orders +19% and project-related business +8%; backlog +15% to $322.5M at March 31, 2025 22
Acquisition 2025-05-28
Announced definitive agreement to acquire Kito Crosby Limited, expected to close in fiscal 2026, funded by $3.05 billion debt financing and $800 million perpetual convertible preferred equity from Clayton, Dubilier & Rice 21
Announced definitive agreement to acquire Kito Crosby Limited, expected to close in fiscal 2026, funded by $3.05 billion debt financing and $800 million perpetual convertible preferred equity from Clayton, Dubilier & Rice 21
Operating income halved 2025-05-28
Operating income more than halved YoY (25.4 to 4.9 USDm, -81%). 130
Operating income more than halved YoY (25.4 to 4.9 USDm, -81%). 130
2025-Q3 · Oct – Dec 2024
„The second half of our third quarter saw a slowing of industry demand. This was driven by delayed customer decision-making related to U.S. policy uncertainty, including tariffs as well as continued weakening in the European economies. Our results reflect lower than expected short-cycle demand which we expect will also impact the fourth quarter. The strengthening of the U.S. dollar negatively impacted earnings per share by $0.11 versus the prior year as well. As the quarter evolved, we executed actions to reduce costs and align capacity with demand, which will remain a focus the fourth quarter.“ – David J. Wilson, President and Chief Executive Officer 19
Revenue decelerating 2025-02-10
Net sales -7.9% to $234.1M, with unfavorable volume of $21.3M and short-cycle orders down 6%; adjusted EPS $0.56 vs $0.74 in prior year, impacted by $0.11 unfavorable FX 18, 19
Net sales -7.9% to $234.1M, with unfavorable volume of $21.3M and short-cycle orders down 6%; adjusted EPS $0.56 vs $0.74 in prior year, impacted by $0.11 unfavorable FX 18, 19
Guidance cut 2025-02-10
FY25 guidance revised to mid-single digit decrease in net sales and low-teens decrease in adjusted EPS, citing policy uncertainty and subdued demand in Europe 19
FY25 guidance revised to mid-single digit decrease in net sales and low-teens decrease in adjusted EPS, citing policy uncertainty and subdued demand in Europe 19
2025-Q2 · Jul – Sep 2024
„Order growth, with particular strength in precision conveyance, and an encouraging funnel of promising opportunities supports our fiscal 2025 guidance and positions us well for fiscal 2026.“ – David J. Wilson, President and Chief Executive Officer 17
Revenue decelerating 2024-10-30
Net sales -6.2% to $242.3M, impacted by Hurricane Helene, Monterrey manufacturing ramp-up, and project timing; orders +16%, book-to-bill 1.08x 17
Net sales -6.2% to $242.3M, impacted by Hurricane Helene, Monterrey manufacturing ramp-up, and project timing; orders +16%, book-to-bill 1.08x 17
Margin compressing 2024-10-30
Gross margin contracted to 30.9% from 38.7%, driven by $10.8M Charlotte impairment and closure costs, $2.2M Monterrey facility startup costs, and $12.3M lower profit from volume decline 16
Gross margin contracted to 30.9% from 38.7%, driven by $10.8M Charlotte impairment and closure costs, $2.2M Monterrey facility startup costs, and $12.3M lower profit from volume decline 16
Guidance initiated 2024-10-30
FY25 guidance issued: net sales flat to low-single digit growth and adjusted EPS mid-single digit growth year-over-year 17
FY25 guidance issued: net sales flat to low-single digit growth and adjusted EPS mid-single digit growth year-over-year 17
Operating income halved 2024-10-30
Operating income more than halved YoY (33.4 to 10.8 USDm, -68%). 16
Operating income more than halved YoY (33.4 to 10.8 USDm, -68%). 16
2025-Q1 · Apr – Jun 2024
„We executed solidly in the first quarter delivering continued sales growth and gross margin expansion while advancing our longer-term strategic objectives. Our commercial and operational initiatives are positively impacting the business enabling new customer wins, growth in attractive vertical markets and an encouraging funnel of promising business opportunities.“ – David J. Wilson, President and Chief Executive Officer 15
revenue 2024-07-31
Net sales +1.8% to $239.7M, supported by $3.5M in price increases and $2.7M montratec contribution; backlog +4% to $292.8M with book-to-bill 1.05x 15
Net sales +1.8% to $239.7M, supported by $3.5M in price increases and $2.7M montratec contribution; backlog +4% to $292.8M with book-to-bill 1.05x 15
Strategic pivot 2024-07-31
Announced relocation of North American linear motion manufacturing from Charlotte, NC to Monterrey, Mexico, with expected restructuring costs of $6.0-9.0 million 14
Announced relocation of North American linear motion manufacturing from Charlotte, NC to Monterrey, Mexico, with expected restructuring costs of $6.0-9.0 million 14
2024 · 13 events
2024-Q4 · Jan – Mar 2024
earnings 2024-05-29
Adjusted EBITDA $166.7M, up 13%, with Adjusted EBITDA Margin of 16.4%, up 60 basis points; FCF $42.4M at 91% free cash flow conversion 13
Adjusted EBITDA $166.7M, up 13%, with Adjusted EBITDA Margin of 16.4%, up 60 basis points; FCF $42.4M at 91% free cash flow conversion 13
revenue 2024-05-29
Record FY2024 net sales of $1.0B, up 8%; Q4 net sales $265.5M, up 5%, with precision conveyance up 23% and Q4 precision conveyance orders up 25% 13
Record FY2024 net sales of $1.0B, up 8%; Q4 net sales $265.5M, up 5%, with precision conveyance up 23% and Q4 precision conveyance orders up 25% 13
Guidance initiated 2024-05-29
FY2025 guidance: low-single digit net sales growth and mid-to-high single digit Adjusted EPS growth year over year; net leverage ratio target of approximately 2.0x by end of FY2025 13
FY2025 guidance: low-single digit net sales growth and mid-to-high single digit Adjusted EPS growth year over year; net leverage ratio target of approximately 2.0x by end of FY2025 13
2024-Q3 · Oct – Dec 2023
„We are pleased with the strong orders, sales, operating income and cash flow generation we delivered in the quarter. Our team continued to execute commercial and operational initiatives, improving productivity, reducing lead times, and enhancing our customer experience. Our top-line growth translated to expanded operating margin demonstrating the incremental leverage of our business as we continue to drive year-over-year improvements leveraging CMBS and the 80/20 process. We have an encouraging funnel for both short cycle and large projects as we continue to execute on our strategy to become a leader in intelligent motion solutions. Our progress gives us confidence in our near- and long-term financial objectives, which we believe will drive meaningful shareholder value.“ – David J. Wilson, President and Chief Executive Officer 11
revenue 2024-01-31
Net sales increased 10.3% to $254.1M, led by strength across all product platforms; precision conveyance orders up 23%, total orders up 8% 11
Net sales increased 10.3% to $254.1M, led by strength across all product platforms; precision conveyance orders up 23%, total orders up 8% 11
Margin expanding 2024-01-31
Gross margin expanded 130 basis points to 36.9%; Adjusted Gross Margin expanded 160 basis points to 37.2% 11
Gross margin expanded 130 basis points to 36.9%; Adjusted Gross Margin expanded 160 basis points to 37.2% 11
Strategic pivot 2024-01-31
Completed construction and occupancy of manufacturing center of excellence in Mexico, providing significant growth capacity and cost savings 11
Completed construction and occupancy of manufacturing center of excellence in Mexico, providing significant growth capacity and cost savings 11
Cash flow inflection 2024-01-31
Operating cash flow reached 29.1 USDm vs 10.8 USDm in 2023-Q3 (×2.7). 10
Operating cash flow reached 29.1 USDm vs 10.8 USDm in 2023-Q3 (×2.7). 10
2024-Q2 · Jul – Sep 2023
„This quarter's record financial performance provides additional proof points that demonstrate progress toward our fiscal 2027 targets. Given these results, we are accelerating debt repayment even as we invest in improving productivity and simplifying our footprint. We now expect our net leverage ratio to be approximately 2.3x1 by the end of fiscal 2024. As we execute our strategy, we are building an enterprise that can deliver stronger growth and increased profitability as we advance the transformation of Columbus McKinnon.“ – David J. Wilson, President and Chief Executive Officer 9
Revenue accelerating 2023-11-01
Record net sales of $258.4M, up 12% year over year, with montratec contributing $9.5M to quarterly sales 9
Record net sales of $258.4M, up 12% year over year, with montratec contributing $9.5M to quarterly sales 9
Margin expanding 2023-11-01
Record gross margin of 38.7%, representing 190 basis points of sequential expansion 9
Record gross margin of 38.7%, representing 190 basis points of sequential expansion 9
2024-Q1 · Apr – Jun 2023
„In our first month of ownership, the montratec acquisition contributed $2.7 million in sales. We are excited about the technology and opportunities that montratec adds to our precision conveying portfolio. We expect strong growth out of the business and look to further its potential, especially as we broaden exposure in the U.S. market. It is important to note that we successfully completed the refinancing of our debt related to the acquisition. This effort resulted in lower cost debt and eliminated the need for testing compliance with our financial covenant. Notably, with our debt reduction plans and growth for the year, we expect to reduce our net debt leverage ratio to under 2.5x1 by the end of the fiscal year.“ – David J. Wilson, President and Chief Executive Officer 7
Revenue accelerating 2023-08-02
Net sales increased 6.9% to $235.5M, driven by $8.5M in price increases, $3.7M in volume growth, and $2.7M from montratec; record backlog reached $355.3M 6 7
Net sales increased 6.9% to $235.5M, driven by $8.5M in price increases, $3.7M in volume growth, and $2.7M from montratec; record backlog reached $355.3M 6 7
Guidance initiated 2023-08-02
Company guided to surpass $1B in FY2024 revenue and reduce net leverage ratio below 2.5x by year-end 7
Company guided to surpass $1B in FY2024 revenue and reduce net leverage ratio below 2.5x by year-end 7
Acquisition 2023-08-02
montratec GmbH acquisition (completed May 31, 2023) contributed $2.7M to Q1 net sales, adding intelligent automation and transport system capabilities 7
montratec GmbH acquisition (completed May 31, 2023) contributed $2.7M to Q1 net sales, adding intelligent automation and transport system capabilities 7
Advertisement
Key Figures ($m)#
The company's core financial figures in three views, one below the other: fiscal years (as reported; after restatements the table shows the most recent filing version, marked), half-years (6-month basis, H2 = second half on its own) and quarters (3-month basis, not cumulative). Each row is one period, most recent first. Values with a dotted underline are clickable and show the raw value, the exact source location, the scale evidence and the source; derived values additionally show their formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
All figures serve only to support your own investment decision and are not a recommendation; the company's original reports are authoritative.
Revenue ($m) · annual basis, as reported
Net income ($m) · annual basis, as reported
EPS ($) · annual basis, as reported
Operating cash flow ($m) · annual basis, as reported
Revenue ($m) · quarterly basis, as reported
Net income ($m) · quarterly basis, as reported
EPS ($) · quarterly basis, as reported
Operating cash flow ($m) · quarterly basis, as reported
Cash ($m) · annual basis, as reported
Debt ($m) · annual basis, as reported
Net Debt ($m) · annual basis, as reported
Capex ($m) · annual basis, as reported
FCF ($m) · annual basis, as reported
D&A ($m) · annual basis, as reported
Cash ($m) · quarterly basis, as reported
Debt ($m) · quarterly basis, as reported
Net Debt ($m) · quarterly basis, as reported
Capex ($m) · quarterly basis, as reported
FCF ($m) · quarterly basis, as reported
D&A ($m) · quarterly basis, as reported
Shown: the most recent fiscal years. Full history since FY2016 is on record.
Fiscal years
Amounts in $m · EPS in $ per share · as reported
| Period | Calendar quarter | Revenue | Op. income | Op. income (adj.) | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | OCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 | Q2/2025–Q1/2026 | 1,193.5 | -119.3 | – | -229.5 | -7.40 | 1.87 | 181.4 | -146.2 | 30 |
| FY2025 | Q2/2024–Q1/2025 | 963 | 54.6 | 102.4 | -5.1 | -0.18 | 2.48 | – | 45.6 | 21 |
| FY2024 | Q2/2023–Q1/2024 | 1,013.5 | 107.1 | 120.7 | 46.6 | 1.61 | 2.86 | – | 67.2 | 12 |
Quarters
Amounts in $m · EPS in $ per share · Net Debt/EBITDA as a multiple · as reported
| Period | Calendar quarter | Published | Revenue | Op. income | Op. income (adj.) | Net income | EPS ($) | EPS adj. ($) | EBITDA (adj.) | FCF | Cash | Net Debt | Net Debt/EBITDA (x) | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2027-Q1* | Q2/2026 | 2026-07-30 | 531.5 | -17.7 | – | -88.4 | -2.05 | 0.61 | 111.5 | 20 | 98.4 | 2,432.4 | – | 133 |
| 2026-Q4* | Q1/2026 | 2026-06-04 | 437.8 | -153.2 | – | -238.1 | -7.68* | 0.24 | 68.7 | -174.3 | 96.6 | 2,462.1 | – | 130 |
| 2026-Q3* | Q4/2025 | 2026-02-09 | 258.7 | 16.2 | 24.5 | 6 | 0.21 | 0.62 | 39.8 | 16.5 | 35.5 | – | – | 28 |
| 2026-Q2* | Q3/2025 | 2025-10-30 | 261 | 12.2 | 25.2 | 4.6 | 0.16 | 0.62 | 0.04 | 15.1 | 28 | – | – | 25 |
| 2026-Q1* | Q2/2025 | 2025-07-30 | 235.9 | 5.5 | 18.5 | -1.9 | -0.07 | 0.50 | 32.6 | -21.4 | 28.7 | – | – | 23 |
| 2025-Q4* | Q1/2025 | 2025-05-28 | 246.9 | 4.9 | 24.1 | -2.7 | -0.09* | 0.60 | 35.6 | 29.5 | 53.7 | 455 | 4.4x (LTM) | 21 |
| 2025-Q3* | Q4/2024 | 2025-02-10 | 234.1 | 17.7 | 25.6 | 4 | 0.14 | 0.56 | 40.3 | 6.2 | 41.2 | – | – | 18 |
| 2025-Q2* | Q3/2024 | 2024-10-30 | 242.3 | 10.8 | 27 | -15 | -0.52 | 0.70 | 39.15 | 3.9 | 55.7 | – | – | 16 |
| 2025-Q1* | Q2/2024 | 2024-07-31 | 239.7 | 21.1 | 25.7 | 8.6 | 0.30 | 0.62 | 37.5 | -15.4 | 68.4 | – | – | 14 |
| 2024-Q4* | Q1/2024 | 2024-05-29 | 265.5 | 25.4 | 31.1 | 11.8 | 0.41* | 0.75 | 0.04 | 30.1 | 114.1 | 453.2 | 3x (LTM) | 12 |
| 2024-Q3* | Q4/2023 | 2024-01-31 | 254.1 | 26.9 | 29.7 | 9.7 | 0.34 | 0.74 | 41.3 | 23.1 | 102.9 | – | – | 10 |
| 2024-Q2* | Q3/2023 | 2023-11-01 | 258.4 | 33.4 | 34.1 | 15.8 | 0.55 | 0.76 | 45.7 | 11.6 | 99.1 | – | – | 8 |
| 2024-Q1* | Q2/2023 | 2023-08-02 | 235.5 | 21.4 | 25.8 | 9.3 | 0.32 | 0.62 | 36.6 | -22.5 | 107 | – | – | 6 |
* derived: values with formula provenance (hover); Q4 = FY − 9M · H2 = FY − H1 · EPS via implied shares · net debt = financial debt − cash · FCF = OCF − |capex|.
Advertisement
Balance Sheet & Cash Flow ($m)#
Point-in-time balance sheet items (e.g. cash, financial debt) and cash flow items (operating cash flow, investments/capex) per fiscal year, half-year and quarter. Balance sheet values are as of the period end, flow items cover the period. Derived values are marked and are calculated, for example, as: net debt = financial debt − cash; free cash flow = operating cash flow − capex; the click popover shows formula and inputs. All values are extracted automatically from the filings; errors are possible; please verify decision-relevant figures yourself by clicking through to the linked original.
Fiscal years
Amounts in $m · as reported
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 | Q2/2025–Q1/2026 | 2026-06-04 | 96.6 | 2,558.6 | 2,462.1 | 77 | -146.2 | 17.9 | -164.1 | 30 |
| FY2025 | Q2/2024–Q1/2025 | 2025-05-28 | 53.7 | 508.7 | 455 | 48.2 | 45.6 | 21.4 | 24.2 | 21 |
| FY2024 | Q2/2023–Q1/2024 | 2024-05-29 | 114.1 | 567.3 | 453.2 | 45.9 | 67.2 | 24.8 | 42.4 | 12 |
Quarters
Amounts in $m · as reported
| Period | Calendar quarter | Published | Cash | Debt | Net Debt | D&A | OCF | Capex | FCF | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2027-Q1 | Q2/2026 | 2026-07-30 | 98.4 | 2,530.8 | 2,432.4 | 53.2 | 25.6 | 5.7 | 20 | 133 |
| 2026-Q4 | Q1/2026 | 2026-06-04 | 96.6 | 2,558.6 | 2,462.1 | 40.4 | -166.8 | 7.5 | -174.3 | 130 |
| 2026-Q3 | Q4/2025 | 2026-02-09 | 35.5 | – | – | 12.1 | 20.3 | 3.8 | 16.5 | 28 |
| 2026-Q2 | Q3/2025 | 2025-10-30 | 28 | – | – | 12.2 | 18.4 | 3.3 | 15.1 | 25 |
| 2026-Q1 | Q2/2025 | 2025-07-30 | 28.7 | – | – | 12.3 | -18.2 | 3.2 | -21.4 | 23 |
| 2025-Q4 | Q1/2025 | 2025-05-28 | 53.7 | 508.7 | 455 | 12 | 35.6 | 6.1 | 29.5 | 21 |
| 2025-Q3 | Q4/2024 | 2025-02-10 | 41.2 | – | – | 12.2 | 11.4 | 5.2 | 6.2 | 18 |
| 2025-Q2 | Q3/2024 | 2024-10-30 | 55.7 | – | – | 12.2 | 9.4 | 5.4 | 3.9 | 16 |
| 2025-Q1 | Q2/2024 | 2024-07-31 | 68.4 | – | – | 11.8 | -10.8 | 4.6 | -15.4 | 14 |
| 2024-Q4 | Q1/2024 | 2024-05-29 | 114.1 | 567.3 | 453.2 | 11.9 | 38.6 | 8.5 | 30.1 | 12 |
| 2024-Q3 | Q4/2023 | 2024-01-31 | 102.9 | – | – | 11.6 | 29.1 | 6 | 23.1 | 10 |
| 2024-Q2 | Q3/2023 | 2023-11-01 | 99.1 | – | – | 11.6 | 16.7 | 5 | 11.6 | 8 |
| 2024-Q1 | Q2/2023 | 2023-08-02 | 107 | – | – | 10.9 | -17.2 | 5.3 | -22.5 | 6 |
Debt = long-term + current · Net debt = debt − cash · FCF = OCF − capex.
Advertisement
Revenue by Type (as of 2027-Q1 · USDm · 12/13)#
Revenue split by segment or product type, exactly as the company itself reports it. The basis is stated next to each value (3, 6 or 12 months); segment totals can deviate from group revenue (reconciliation/consolidation items). If the company changes its segment structure, older structures are kept in the expandable part. Rows in grey are no longer reported separately by the company; they show the last available figures and are never extrapolated.
| Segment | Since | Period | Basis | Revenue | Source |
|---|---|---|---|---|---|
| Crane Solutions | 2025-Q1 | 2026-Q1 | 3M | 95.2 | 23 |
| Industrial Products | 2025-Q1 | 2026-Q1 | 3M | 83.2 | 23 |
| Precision Conveyor Products | 2025-Q1 | 2026-Q1 | 3M | 35.9 | 23 |
| Engineered Products | 2025-Q1 | 2026-Q1 | 3M | 21.7 | 23 |
| Actuators and rotary unions | – | FY2026 | – | – | 31 |
| Digital power control and delivery systems | – | FY2026 | – | – | 31 |
| Elevator application drive systems | – | FY2026 | – | – | 31 |
| High-precision conveying systems | – | FY2026 | – | – | 31 |
| Hoists | – | FY2026 | – | – | 31 |
| Industrial cranes | – | FY2026 | – | – | 31 |
| Lifting and securement hardware | – | FY2026 | – | – | 31 |
| Technology & Specialty Solutions | – | FY2026 | – | – | 31 |
| Chain and rigging tools | – | FY2024 | – | – | 12 |
Advertisement
M&A (9)#
All recorded acquisitions (purchases) and divestitures/exits with date, short description and source; deliberately including smaller transactions that summaries often miss. Purchase prices appear only where the company itself has disclosed them. Rows in grey are cancelled transactions; the cancellation date is shown in the row.
Acquisitions · 3Divestitures/exits · 4older: 2 (in the table)
Acquisitions
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| North American linear motion facility consolidation to Monterrey, Mexico (2×) | 2024-07 | Completed | 14 |
| Kito Acquisition (4×) | 2024 | Completed | 27 |
| montratec acquisition | 2023-05 | Completed | 32 |
| Garvey acquisition | 2021-12 | Completed | 4 |
| Dorner acquisition (2×) | 2021-04 | Completed | 4 |
Divestitures / exits
| Transaction / stake | Date | Type | Source |
|---|---|---|---|
| Divestiture Business sale | 2026-04 | Divested | 28 |
| Divestiture of U.S. power chain hoist and chain operations (3×) | 2026 | Divested | 33 |
| Precision Conveyance operations closures | 2025 | Divested | 21 |
| Charlotte Manufacturing Operations closure | 2024 | Divested | 21 |
Advertisement
Reported KPIs (as disclosed) (386)#
Figures the company discloses itself in addition to the standard financials; order intake, recurring revenue, user or unit counts, adjusted measures. These “story KPIs” usually slip through standard databases; here they are collected as reported, with no calculation of our own. Important: the definition comes from the company itself and can differ from firm to firm; period and source are stated next to every value.
Company-specific KPIs verbatim from the filings (English, as disclosed; not normalised). Balance-sheet and boilerplate items filtered.
| Date | Period | KPI | Value / change | Source |
|---|---|---|---|---|
| 2026-07-30 | 2027-Q1 | Total liquidity | 567.1 | 33 |
| 2026-07-30 | 2027-Q1 | Selling expenses as % of sales | 10.3% | 32 |
| 2026-07-30 | 2027-Q1 | Research and development expenses as % of sales | 1.6% | 32 |
| 2026-07-30 | 2027-Q1 | Orders | 568.1 (USD millions) | 33 |
| 2026-07-30 | 2027-Q1 | Liquidity | 567,148,000 | 32 |
| 2026-07-30 | 2027-Q1 | Gross profit margin | 27.5% | 32 |
| 2026-07-30 | 2027-Q1 | General and administrative expenses as % of sales | 12.3% | 32 |
| 2026-07-30 | 2027-Q1 | Foreign cash held by subsidiaries | 92,794,000 (USD millions) | 32 |
| 2026-07-30 | 2027-Q1 | Credit Agreement Net Leverage Ratio | 4.9x | 33 |
| 2026-07-30 | 2027-Q1 | Cash and cash equivalents | 98,410,000 (USD millions) | 32 |
| 2026-07-30 | 2027-Q1 | Capital expenditures - Q1 2026 | 5,668,000 (USD millions) | 32 |
| 2026-07-30 | 2027-Q1 | Capital expenditures - Q1 2025 | 3,202,000 (USD millions) | 32 |
| 2026-07-30 | 2027-Q1 | Book to Bill | 1.1x | 33 |
| 2026-07-30 | 2027-Q1 | Adjusted Gross Margin | 38.1 | 33 |
| 2026-07-30 | 2027-Q1 | Adjusted EBITDA Margin | 21.0 | 33 |
| 2026-06-08 | FY2026 | Total Addressable Market | $35 billion | 31 |
| 2026-06-08 | FY2026 | Safety incident rate (prior year) | 0.54 | 31 |
| 2026-06-08 | FY2026 | Safety incident rate (Kito Crosby) | 0.86 | 31 |
| 2026-06-08 | FY2026 | Safety incident rate (Columbus McKinnon) | 0.38 | 31 |
| 2026-06-08 | FY2026 | Backlog | $519,639,000 | 31 |
| 2026-06-04 | FY2026 | Total liquidity | 561.2 million | 30 |
| 2026-06-04 | FY2026 | Orders | 1.2 billion | 30 |
| 2026-06-04 | FY2026 | Long-term backlog as % of total backlog | 50.8% | 30 |
| 2026-06-04 | FY2026 | Long-term backlog (Expected to ship beyond 3 months) | 263.7 million | 30 |
| 2026-06-04 | FY2026 | Days sales outstanding | 65.8 days | 30 |
| 2026-06-04 | FY2026 | Credit Agreement Net Leverage Ratio | 5.1x | 30 |
| 2026-06-04 | FY2026 | Backlog | 519.6 million | 30 |
| 2026-02-09 | 2026-Q3 | Working capital as a % of sales | 23.4 (USD millions) | 29 |
| 2026-02-09 | 2026-Q3 | Precision Conveyance reporting unit fair value excess | 2.6% | 28 |
| 2026-02-09 | 2026-Q3 | Long-term backlog as % of total backlog | 61.4 (USD millions) | 29 |
| 2026-02-09 | 2026-Q3 | Long-term backlog | 209.8 (USD millions) | 29 |
| 2026-02-09 | 2026-Q3 | Geographic revenue diversification | 43% of net sales from customers outside the U.S. | 28 |
| 2026-02-09 | 2026-Q3 | Debt, net of cash, to net total capitalization | 31.0 (USD millions) | 29 |
| 2026-02-09 | 2026-Q3 | Debt to total capitalization percentage | 32.8 | 29 |
| 2026-02-09 | 2026-Q3 | Days sales outstanding | 61.3 | 29 |
| 2026-02-09 | 2026-Q3 | Backlog | 341.6 (USD millions) | 29 |
| 2026-01-14 | 2026-Q3 | Orders received | 245 million to 250 million | 27 |
| 2026-01-14 | 2026-Q3 | Backlog | 335 million to 345 million | 27 |
| 2025-10-30 | 2026-Q2 | Working capital as a % of sales | 24.3% | 26 |
| 2025-10-30 | 2026-Q2 | Selling expenses as % of sales (six months) | 11.6% | 25 |
| 2025-10-30 | 2026-Q2 | Selling expenses as % of sales (Q2) | 11.2% | 25 |
| 2025-10-30 | 2026-Q2 | Research and development expenses as % of sales (six months) | 1.9% | 25 |
| 2025-10-30 | 2026-Q2 | Research and development expenses as % of sales (Q2) | 1.8% | 25 |
| 2025-10-30 | 2026-Q2 | Operating cash flow (six months) | $248,000 | 25 |
| 2025-10-30 | 2026-Q2 | Long-term backlog as % of total backlog | 60.4% | 26 |
| 2025-10-30 | 2026-Q2 | Long-term backlog | 212.4 (USD millions) | 26 |
| 2025-10-30 | 2026-Q2 | Gross profit margin (six months) | 33.7% | 25 |
| 2025-10-30 | 2026-Q2 | Gross profit margin (Q2) | 34.5% | 25 |
| 2025-10-30 | 2026-Q2 | Geographic revenue mix (outside U.S.) | 43% | 25 |
| 2025-10-30 | 2026-Q2 | General and administrative expenses as % of sales (six months) | 13.5% | 25 |
| 2025-10-30 | 2026-Q2 | General and administrative expenses as % of sales (Q2) | 13.9% | 25 |
| 2025-10-30 | 2026-Q2 | Free Cash Flow | 15.1 (USD millions) | 26 |
| 2025-10-30 | 2026-Q2 | Foreign subsidiaries cash holdings | $24,798,000 | 25 |
| 2025-10-30 | 2026-Q2 | Debt, net of cash, to net total capitalization | 32.0% | 26 |
| 2025-10-30 | 2026-Q2 | Debt to total capitalization percentage | 33.4% | 26 |
| 2025-10-30 | 2026-Q2 | Days sales outstanding | 62.5 | 26 |
| 2025-10-30 | 2026-Q2 | Cash, cash equivalents, and restricted cash | $28,289,000 | 25 |
| 2025-10-30 | 2026-Q2 | Capital expenditures (six months) | $6,523,000 | 25 |
| 2025-10-30 | 2026-Q2 | Backlog | 351.6 (USD millions) | 26 |
| 2025-07-30 | 2026-Q1 | Unsatisfied performance obligations | 45,875 | 23 |
| 2025-07-30 | 2026-Q1 | Total shareholders equity | 910,883 | 23 |
| 2025-07-30 | 2026-Q1 | Total liabilities | 868,309 | 23 |
| 2025-07-30 | 2026-Q1 | Total current liabilities | 259,239 | 23 |
| 2025-07-30 | 2026-Q1 | Total current assets | 478,476 (USD in thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Total assets | 1,779,192 (USD in thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Cash and cash equivalents | 28,722 (USD in thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Working capital as a % of sales | 25.2% | 24 |
| 2025-07-30 | 2026-Q1 | Unsecured lines for bank guarantees utilized | 14,817,000 | 23 |
| 2025-07-30 | 2026-Q1 | Unsecured lines for bank guarantees available | 21,570,000 | 23 |
| 2025-07-30 | 2026-Q1 | Terminated plan surplus to be utilized in next twelve months | 2,340,000 | 23 |
| 2025-07-30 | 2026-Q1 | Terminated plan surplus | 5,633,000 | 23 |
| 2025-07-30 | 2026-Q1 | Term Loan B outstanding principal balance | 432,560,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Stock-based compensation | 1,842,000 | 23 |
| 2025-07-30 | 2026-Q1 | Share repurchase authorization remaining | 9,055,000 | 23 |
| 2025-07-30 | 2026-Q1 | Selling expenses Q1 FY2026 | 28,531,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Selling expenses Q1 FY2025 | 27,770,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Selling expenses % of net sales FY2026 | 12.1% | 23 |
| 2025-07-30 | 2026-Q1 | Selling expenses % of net sales FY2025 | 11.6% | 23 |
| 2025-07-30 | 2026-Q1 | Revolving Credit Facility size | 175,000,000 | 23 |
| 2025-07-30 | 2026-Q1 | R&D expenses Q1 FY2026 | 4,821,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | R&D expenses Q1 FY2025 | 6,166,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | R&D expenses % of net sales FY2026 | 2.0% | 23 |
| 2025-07-30 | 2026-Q1 | R&D expenses % of net sales fiscal 2025 | 2.6% | 23 |
| 2025-07-30 | 2026-Q1 | Raw material and component purchases fiscal 2025 | 375 million | 23 |
| 2025-07-30 | 2026-Q1 | Product-related aggregate liability probable and estimable | 4,861,000 | 23 |
| 2025-07-30 | 2026-Q1 | Product liability jury verdict | 3,000,000 | 23 |
| 2025-07-30 | 2026-Q1 | Orders | 258.6 million | 24 |
| 2025-07-30 | 2026-Q1 | Operating lease expense Q1 FY2026 | 3,608,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Operating lease expense Q1 FY2025 | 3,704,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Non-cash lease expense | 2,412,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Non-U.S. unsecured credit lines available | 3,182,000 | 23 |
| 2025-07-30 | 2026-Q1 | Net sales Q1 FY2026 | 235,920,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Net sales Q1 FY2025 | 239,726,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Net loss Q1 FY2026 | (1,898,000) | 23 |
| 2025-07-30 | 2026-Q1 | Magnetek asbestos-related liability | 1,167,000 | 23 |
| 2025-07-30 | 2026-Q1 | Long-term backlog as % of total backlog | 62.0% | 24 |
| 2025-07-30 | 2026-Q1 | Long-term backlog | 223.4 million | 24 |
| 2025-07-30 | 2026-Q1 | Investment income Q1 FY2026 | 1,049,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Investment income Q1 FY2025 | 209,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Interest and debt expense Q1 FY2026 | 8,698,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Interest and debt expense Q1 FY2025 | 8,235,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Interest and debt expense - finance lease Q1 FY2026 | 136,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Interest and debt expense - finance lease Q1 FY2025 | 144,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Increase in prepaid expenses | 3,015,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Increase in accrued expenses | 2,902,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Income tax expense Q1 FY2026 (ended Jun 30, 2025) | 260,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Income tax expense Q1 FY2025 (ended Jun 30, 2024) | 3,421,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Income tax expense % of pre-tax loss | 16% | 23 |
| 2025-07-30 | 2026-Q1 | Income tax expense % of pre-tax income | 28% | 23 |
| 2025-07-30 | 2026-Q1 | Gross profit margin Q1 FY2026 | 32.7% | 23 |
| 2025-07-30 | 2026-Q1 | Gross profit margin Q1 FY2025 | 37.1% | 23 |
| 2025-07-30 | 2026-Q1 | Net sales outside U.S. | 43% | 23 |
| 2025-07-30 | 2026-Q1 | G&A expenses Q1 FY2026 (ended Jun 30, 2025) | 30,743,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | G&A expenses Q1 FY2025 (ended Jun 30, 2024) | 26,447,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | G&A expenses % of net sales FY2026 | 13.0% | 23 |
| 2025-07-30 | 2026-Q1 | G&A expenses % of net sales FY2025 | 11.0% | 23 |
| 2025-07-30 | 2026-Q1 | Free Cash Flow | -21.4 million | 24 |
| 2025-07-30 | 2026-Q1 | Cash and cash equivalents, foreign subsidiaries | 26,517,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Finance lease obligation, outstanding balance | 12,092,000 | 23 |
| 2025-07-30 | 2026-Q1 | Finance lease expense Q1 FY2026 (ended Jun 30, 2025) | 250,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Finance lease expense Q1 FY2025 (ended Jun 30, 2024) | 250,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Dividend per common share (Jul 21, 2025) | 0.07 | 23 |
| 2025-07-30 | 2026-Q1 | Dividend payments Q1 FY2026 (ended Jun 30, 2025) | 2,003,000 | 23 |
| 2025-07-30 | 2026-Q1 | Dividend payment expected | 2,010,000 | 23 |
| 2025-07-30 | 2026-Q1 | D&A | 12,266,000 | 23 |
| 2025-07-30 | 2026-Q1 | Debt, net of cash, to net total capitalization | 32.8% | 24 |
| 2025-07-30 | 2026-Q1 | Debt to total capitalization percentage | 34.2% | 24 |
| 2025-07-30 | 2026-Q1 | Days sales outstanding | 69.5 days | 24 |
| 2025-07-30 | 2026-Q1 | Changes in working capital reduction | 26,703,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Cash inflow from hedging activities | (443,000) | 23 |
| 2025-07-30 | 2026-Q1 | Operating cash flow Q1 FY2026 (Apr-Jun 2025) | (18,153,000) | 23 |
| 2025-07-30 | 2026-Q1 | Operating cash flow Q1 FY2025 (Apr-Jun 2024) | (10,758,000) | 23 |
| 2025-07-30 | 2026-Q1 | Investing cash flow Q1 FY2026 (Apr-Jun 2025) | (3,217,000) | 23 |
| 2025-07-30 | 2026-Q1 | Investing cash flow Q1 FY2025 (Apr-Jun 2024) | (4,041,000) | 23 |
| 2025-07-30 | 2026-Q1 | Financing cash flow Q1 FY2026 (Apr-Jun 2025) | (977,000) | 23 |
| 2025-07-30 | 2026-Q1 | Financing cash flow Q1 FY2025 (Apr-Jun 2024) | (30,583,000) | 23 |
| 2025-07-30 | 2026-Q1 | Cash and cash equivalents Mar 31, 2025 | 53,933,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Cash and cash equivalents Jun 30, 2025 | 28,972,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Capex Q1 FY2026 (Apr-Jun 2025) | 3,202,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Capex Q1 FY2025 (Apr-Jun 2024) | 4,629,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Capex expected FY2026 | 20,000,000 to 25,000,000 | 23 |
| 2025-07-30 | 2026-Q1 | Bridgeport facility environmental liability | 550,000 | 23 |
| 2025-07-30 | 2026-Q1 | Book-to-Bill Ratio | 1.1x | 24 |
| 2025-07-30 | 2026-Q1 | Backlog | 360.1 million | 24 |
| 2025-07-30 | 2026-Q1 | Asbestos-related aggregate liability probable and estimable | 5,889,000 | 23 |
| 2025-07-30 | 2026-Q1 | Asbestos-related aggregate liability estimated range low | 4,300,000 | 23 |
| 2025-07-30 | 2026-Q1 | Asbestos-related aggregate liability estimated range high | 7,900,000 | 23 |
| 2025-07-30 | 2026-Q1 | Asbestos expected liability payments next 12 months | 2,600,000 | 23 |
| 2025-07-30 | 2026-Q1 | Additional debt borrowings Q1 FY2026 (Apr-Jun 2025) | 2,225,000 (USD thousands) | 23 |
| 2025-07-30 | 2026-Q1 | Accrued general and product liability gross | 18,804,000 | 23 |
| 2025-07-30 | 2026-Q1 | Accrued general and product liability estimated insurance recoveries | 6,887,000 | 23 |
| 2025-07-30 | 2026-Q1 | AR Securitization Facility borrowings outstanding | 32,400,000 | 23 |
| 2025-07-30 | 2026-Q1 | AR Securitization Facility borrowing base | 55,000,000 | 23 |
| 2025-05-28 | FY2025 | Term Loan B outstanding | 437.6 million | 21 |
| 2025-05-28 | FY2025 | Selling expenses | 110,043,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Research and development expenses | 23,869,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Principal raw materials and components purchases | 375 million | 21 |
| 2025-05-28 | FY2025 | Other expense | 25,775,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Liquidity | 240,155,000 | 21 |
| 2025-05-28 | FY2025 | Investment income | 1,302,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Interest rate swaps aggregate notional amount | 355,000,000 | 21 |
| 2025-05-28 | FY2025 | Interest and debt expense | 32,426,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | General and administrative expenses | 107,249,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Foreign currency forward agreements notional amount | 36,528,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Cross currency swap agreement notional amount | 72,040,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Cash and cash equivalents | 53,933,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Capital Expenditures | 21,411,000 (USD millions) | 21 |
| 2025-05-28 | FY2025 | Availability on Revolver | 159,583,000 | 21 |
| 2025-05-28 | FY2025 | Availability on AR Securitization | 26,889,000 | 21 |
| 2025-05-28 | FY2025 | AR Securitization Facility outstanding | 25.0 million | 21 |
| 2025-05-28 | 2025-Q4 | Working capital as a % of sales | 21.3% | 22 |
| 2025-05-28 | 2025-Q4 | Long-term backlog as % of total backlog | 59.0% | 22 |
| 2025-05-28 | 2025-Q4 | Long-term backlog (Expected to ship beyond 3 months) | 190.3 (USD millions) | 22 |
| 2025-05-28 | 2025-Q4 | Free Cash Flow | 29.5 (USD millions) | 22 |
| 2025-05-28 | 2025-Q4 | Debt, net of cash, to net total capitalization | 32.1% | 22 |
| 2025-05-28 | 2025-Q4 | Debt to total capitalization percentage | 34.8% | 22 |
| 2025-05-28 | 2025-Q4 | Days sales outstanding | 61.0 | 22 |
| 2025-05-28 | 2025-Q4 | Backlog | 322.5 (USD millions) | 22 |
| 2025-02-10 | 2025-Q3 | Operating cash flow | $10,000,000 | 18 |
| 2025-02-10 | 2025-Q3 | Net Leverage Ratio | 3.00x | 19 |
| 2025-02-10 | 2025-Q3 | Long-term backlog | 166.1 (USD millions) | 19 |
| 2025-02-10 | 2025-Q3 | Days sales outstanding | 61.0 days | 19 |
| 2025-02-10 | 2025-Q3 | Cash and cash equivalents | $41,474,000 | 18 |
| 2025-02-10 | 2025-Q3 | Capital expenditures | $15,266,000 | 18 |
| 2025-02-10 | 2025-Q3 | Backlog | 296.5 (USD millions) | 19 |
| 2025-02-10 | 2025-Q3 | Adjusted Operating Margin | 10.9% | 19 |
| 2025-02-10 | 2025-Q3 | Adjusted Gross Margin | 36.8% | 19 |
| 2025-02-10 | 2025-Q3 | Adjusted EBITDA Margin | 16.1% | 19 |
| 2024-10-30 | 2025-Q2 | Working capital pct of sales | 23.3% | 17 |
| 2024-10-30 | 2025-Q2 | Raw materials and components purchases | 396 million | 16 |
| 2024-10-30 | 2025-Q2 | Precision conveyance growth | 42% | 17 |
| 2024-10-30 | 2025-Q2 | Percentage of net sales from customers outside the U.S. | approximately 45% | 16 |
| 2024-10-30 | 2025-Q2 | Orders growth | 16% | 17 |
| 2024-10-30 | 2025-Q2 | Net leverage ratio | 2.71x | 17 |
| 2024-10-30 | 2025-Q2 | Net debt to capitalization | 33.2% | 17 |
| 2024-10-30 | 2025-Q2 | Long term backlog pct | 54.3% | 17 |
| 2024-10-30 | 2025-Q2 | Long term backlog | 172.5 (USD millions) | 17 |
| 2024-10-30 | 2025-Q2 | Debt to capitalization | 35.8% | 17 |
| 2024-10-30 | 2025-Q2 | Days sales outstanding | 64.1 days | 17 |
| 2024-10-30 | 2025-Q2 | Cash held by foreign subsidiaries | 44,387,000 (USD millions) | 16 |
| 2024-10-30 | 2025-Q2 | Book to bill ratio | 1.08x | 17 |
| 2024-10-30 | 2025-Q2 | Backlog | 317.6 (USD millions) | 17 |
| 2024-07-31 | 2025-Q1 | Total shareholders equity | 885,806 | 14 |
| 2024-07-31 | 2025-Q1 | Total liabilities | 895,851 | 14 |
| 2024-07-31 | 2025-Q1 | Total current liabilities | 231,505 | 14 |
| 2024-07-31 | 2025-Q1 | Total current assets | 478,311 (USD in thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Total assets | 1,781,657 (USD in thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Cash and cash equivalents | 68,373 (USD in thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Working capital as a % of sales | 22.5% | 15 |
| 2024-07-31 | 2025-Q1 | Unsecured lines available for bank guarantees | 13,766,000 | 14 |
| 2024-07-31 | 2025-Q1 | Unsecured credit lines available | 2,357,000 | 14 |
| 2024-07-31 | 2025-Q1 | Total environmental matters accrued liability | 752,000 | 14 |
| 2024-07-31 | 2025-Q1 | Stock-based compensation | 1,101,000 | 14 |
| 2024-07-31 | 2025-Q1 | Standby letters of credit | 15,630,000 | 14 |
| 2024-07-31 | 2025-Q1 | Selling expenses fiscal 2025 Q1 | 27,770,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Selling expenses fiscal 2024 Q1 | 24,981,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Selling expenses as % of sales Q1 FY2025 | 11.6% | 14 |
| 2024-07-31 | 2025-Q1 | Selling expenses as % of sales Q1 FY2024 | 10.6% | 14 |
| 2024-07-31 | 2025-Q1 | R&D expenses Q1 FY2025 | 6,166,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | R&D expenses Q1 FY2024 | 5,900,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | R&D expenses as % of sales Q1 FY2025 | 2.6% | 14 |
| 2024-07-31 | 2025-Q1 | R&D expenses as % of sales Q1 FY2024 | 2.5% | 14 |
| 2024-07-31 | 2025-Q1 | Product-related aggregate liability probable and estimable | 5,166,000 | 14 |
| 2024-07-31 | 2025-Q1 | Product liability jury verdict | 3,000,000 | 14 |
| 2024-07-31 | 2025-Q1 | Prepaid expenses increase | 2,222,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Power-One China Subsidiary Italian tax assessment penalties 2003-2004 | 2,400,000 | 14 |
| 2024-07-31 | 2025-Q1 | Power-One China Subsidiary Italian tax assessment penalties 2002-2006 | 3,000,000 | 14 |
| 2024-07-31 | 2025-Q1 | Power-One China Subsidiary Italian tax assessment period 2003-2004 | 2,000,000 | 14 |
| 2024-07-31 | 2025-Q1 | Power-One China Subsidiary Italian tax assessment periods 2002-2006 | 7,200,000 | 14 |
| 2024-07-31 | 2025-Q1 | Term Loan B outstanding principal | 462,560,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Letters of credit outstanding under Amended and Restated Revolving Credit Facility | 15,630,000 | 14 |
| 2024-07-31 | 2025-Q1 | Outstanding borrowings under AR Securitization Facility | 40,000,000 | 14 |
| 2024-07-31 | 2025-Q1 | Finance lease obligation outstanding balance | 12,779,000 | 14 |
| 2024-07-31 | 2025-Q1 | Operating lease expense Q1 2024 | 3,704,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Operating lease expense Q1 2023 | 3,062,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Operating lease ROU assets | 68,765,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Non-cash lease expense | 2,584,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net sales Q1 FY2025 | 239,726,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net sales three months ended June 30, 2023 | 235,492,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net cash used in operating activities three months ended June 30, 2024 | -10,758,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net cash used for operating activities three months ended June 30, 2023 | -17,247,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net cash used for investing activities three months ended June 30, 2024 | -4,041,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net cash used for investing activities three months ended June 30, 2023 | -112,684,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net cash used for financing activities three months ended June 30, 2024 | -30,583,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Net cash provided by financing activities three months ended June 30, 2023 | 103,985,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Magnetek asbestos-related liability | 914,000 | 14 |
| 2024-07-31 | 2025-Q1 | Long-term backlog as % of total backlog | 53.3% | 15 |
| 2024-07-31 | 2025-Q1 | Long-term backlog | 156.0 (USD in millions) | 15 |
| 2024-07-31 | 2025-Q1 | Investment income 2024 Q1 | 209,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Investment income 2023 Q1 | 543,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Interest and debt expense related to finance lease 2024 | 144,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Interest and debt expense related to finance lease 2023 | 151,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Interest and debt expense 2024 Q1 | 8,235,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Interest and debt expense 2023 Q1 | 8,625,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Hedging activities cash flow inflow | 122,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Gross profit margin fiscal 2025 Q1 | 37.1% | 14 |
| 2024-07-31 | 2025-Q1 | Gross profit margin fiscal 2024 Q1 | 36.8% | 14 |
| 2024-07-31 | 2025-Q1 | Gross proceeds from debt issuance 2023 | 120,000,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Gross balance of deferred financing costs on Term Loan B | 7,845,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Gross balance of deferred financing costs associated with Amended and Restated Revolving Credit Facility | 4,828,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Gross balance of deferred financing costs associated with AR Securitization Facility | 536,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | General and product liability reserve net of insurance recoveries | 12,093,000 | 14 |
| 2024-07-31 | 2025-Q1 | General and product liability reserve gross of insurance recoveries | 19,123,000 | 14 |
| 2024-07-31 | 2025-Q1 | G&A expenses fiscal 2025 Q1 | 26,447,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | G&A expenses fiscal 2024 Q1 | 27,443,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | G&A expenses as % of sales fiscal 2025 Q1 | 11.0% | 14 |
| 2024-07-31 | 2025-Q1 | G&A expenses as % of sales fiscal 2024 Q1 | 11.7% | 14 |
| 2024-07-31 | 2025-Q1 | Free Cash Flow | (15.4) | 15 |
| 2024-07-31 | 2025-Q1 | Foreign cash and cash equivalents | 51,126,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Finance lease within current portion of long-term debt | 687,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Finance lease expense | 250,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Estimated insurance recoveries for general and product liability | 7,030,000 | 14 |
| 2024-07-31 | 2025-Q1 | Estimated effective tax rate fiscal 2025 | 24% to 26% | 14 |
| 2024-07-31 | 2025-Q1 | Effective tax rate continuing operations 2024 Q1 | 28% | 14 |
| 2024-07-31 | 2025-Q1 | Effective tax rate continuing operations 2023 Q1 | 27% | 14 |
| 2024-07-31 | 2025-Q1 | Dividend per common share | 0.07 | 14 |
| 2024-07-31 | 2025-Q1 | Dividend payment | 2,016,000 | 14 |
| 2024-07-31 | 2025-Q1 | Dividend expected payment | 2,020,000 | 14 |
| 2024-07-31 | 2025-Q1 | D&A | 11,840,000 | 14 |
| 2024-07-31 | 2025-Q1 | Debt, net of cash, to net total capitalization | 33.3% | 15 |
| 2024-07-31 | 2025-Q1 | Debt to total capitalization percentage | 36.6% | 15 |
| 2024-07-31 | 2025-Q1 | Debt repayments | 20,158,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Days sales outstanding | 63.3 days | 15 |
| 2024-07-31 | 2025-Q1 | Contingent consideration payment Montratec | 6,711,000 | 14 |
| 2024-07-31 | 2025-Q1 | Changes in working capital impact | -34,729,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Cash and cash equivalents three months ended March 31, 2024 | 114,376,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Cash and cash equivalents three months ended June 30, 2024 | 68,623,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Capex Q1 FY2025 (Apr-Jun 2024) | 4,629,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Capital expenditures three months ended June 30, 2023 | 5,273,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Capex expected fiscal 2025 low | 20,000,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Capex expected fiscal 2025 high | 30,000,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Bridgeport facility environmental liability recorded | 420,000 | 14 |
| 2024-07-31 | 2025-Q1 | Book-to-bill ratio | 1.05x | 15 |
| 2024-07-31 | 2025-Q1 | Bank guarantees utilized | 10,256,000 | 14 |
| 2024-07-31 | 2025-Q1 | Backlog | 292.8 (USD in millions) | 15 |
| 2024-07-31 | 2025-Q1 | Asbestos-related aggregate liability probable and estimable | 6,013,000 | 14 |
| 2024-07-31 | 2025-Q1 | Asbestos-related aggregate liability estimated range low | 4,900,000 | 14 |
| 2024-07-31 | 2025-Q1 | Asbestos-related aggregate liability estimated range high | 8,900,000 | 14 |
| 2024-07-31 | 2025-Q1 | Asbestos liability gross of insurance recoveries | 13,043,000 | 14 |
| 2024-07-31 | 2025-Q1 | Asbestos liability expected payments next 12 months | 2,700,000 | 14 |
| 2024-07-31 | 2025-Q1 | Accumulated amortization on Term Loan B | 3,280,000 (USD thousands) | 14 |
| 2024-07-31 | 2025-Q1 | Accumulated amortization on Amended and Restated Revolving Credit Facility as of March 31, 2024 | 2,655,000 | 14 |
| 2024-07-31 | 2025-Q1 | Accumulated amortization on Amended and Restated Revolving Credit Facility as of June 30, 2024 | 2,924,000 | 14 |
| 2024-07-31 | 2025-Q1 | Accumulated amortization on AR Securitization Facility as of March 31, 2024 | 149,000 | 14 |
| 2024-07-31 | 2025-Q1 | Accumulated amortization on AR Securitization Facility as of June 30, 2024 | 193,000 | 14 |
| 2024-07-31 | 2025-Q1 | Accrued expenses decrease | 11,600,000 (USD thousands) | 14 |
| 2024-05-29 | FY2024 | US sales | $574,843,000 | 12 |
| 2024-05-29 | FY2024 | Raw materials % of COGS | 62% | 12 |
| 2024-05-29 | FY2024 | Raw materials and components | $396 million | 12 |
| 2024-05-29 | FY2024 | Prior year backlog | $308,717,000 | 12 |
| 2024-05-29 | FY2024 | Non-US sales % | 43% | 12 |
| 2024-05-29 | FY2024 | Non-US sales | $438,697,000 | 12 |
| 2024-05-29 | FY2024 | Backlog | $280,824,000 | 12 |
| 2024-05-29 | FY2024 | Terminal growth rate for Precision Conveyance | 3.0% | 12 |
| 2024-05-29 | FY2024 | Revenue CAGR - Precision Conveyance | 13.0% | 12 |
| 2024-05-29 | FY2024 | Projected 10% USD change impact on operating income | $6,450,000 | 12 |
| 2024-05-29 | FY2024 | Net sales from foreign jurisdictions | 43% | 12 |
| 2024-05-29 | FY2024 | Expected AOCL reclassification to interest expense | $5,644,000 | 12 |
| 2024-05-29 | FY2024 | Expected AOCL reclassification to foreign currency exchange loss | $148,000 | 12 |
| 2024-05-29 | FY2024 | Expected AOCL reclassification from foreign currency forward agreements | $71,000 | 12 |
| 2024-05-29 | FY2024 | Assets in United Arab Emirates | $6,280,000 | 12 |
| 2024-05-29 | 2024-Q4 | Working capital as a % of sales | 19.1 (USD millions) | 13 |
| 2024-05-29 | 2024-Q4 | Net Leverage Ratio | 2.40x | 13 |
| 2024-05-29 | 2024-Q4 | Long-term backlog as % of total backlog | 51.5 (USD millions) | 13 |
| 2024-05-29 | 2024-Q4 | Long-term backlog (Expected to ship beyond 3 months) | 144.6 (USD in millions) | 13 |
| 2024-05-29 | 2024-Q4 | Debt, net of cash, to net total capitalization | 32.0 (USD millions) | 13 |
| 2024-05-29 | 2024-Q4 | Debt to total capitalization percentage | 37.5 | 13 |
| 2024-05-29 | 2024-Q4 | Days sales outstanding | 58.7 | 13 |
| 2024-05-29 | 2024-Q4 | Backlog | 280.8 (USD in millions) | 13 |
| 2024-01-31 | 2024-Q3 | Working capital as a % of sales | 20.6 (USD millions) | 11 |
| 2024-01-31 | 2024-Q3 | Long-term backlog as % of total backlog | 50.7 (USD millions) | 11 |
| 2024-01-31 | 2024-Q3 | Long-term backlog | 151.3 (USD in millions) | 11 |
| 2024-01-31 | 2024-Q3 | Gross profit margin (Q3 FY2024) | 36.9% | 10 |
| 2024-01-31 | 2024-Q3 | Gross profit margin (9M FY2024) | 37.5% | 10 |
| 2024-01-31 | 2024-Q3 | Free cash flow | 23.1 (USD in millions) | 11 |
| 2024-01-31 | 2024-Q3 | Debt, net of cash, to net total capitalization | 33.7 (USD millions) | 11 |
| 2024-01-31 | 2024-Q3 | Debt to total capitalization percentage | 38.5 | 11 |
| 2024-01-31 | 2024-Q3 | Days sales outstanding | 62.1 | 11 |
| 2024-01-31 | 2024-Q3 | Cash, cash equivalents, and restricted cash | 103,195,000 (USD thousands) | 10 |
| 2024-01-31 | 2024-Q3 | Backlog | 298.4 (USD in millions) | 11 |
| 2023-11-01 | 2024-Q2 | Selling expenses % Q2 prior year | 11.1% | 8 |
| 2023-11-01 | 2024-Q2 | Selling expenses % Q2 | 10.4% | 8 |
| 2023-11-01 | 2024-Q2 | Selling expenses % 6M prior year | 11.5% | 8 |
| 2023-11-01 | 2024-Q2 | Selling expenses % 6M | 10.5% | 8 |
| 2023-11-01 | 2024-Q2 | Revenue from customers outside US | approximately 43% | 8 |
| 2023-11-01 | 2024-Q2 | Raw materials as % of cost of products sold | 61% | 8 |
| 2023-11-01 | 2024-Q2 | Raw materials and components purchases FY2023 | $365 million | 8 |
| 2023-11-01 | 2024-Q2 | R&D expenses % Q2 prior year | 2.4% | 8 |
| 2023-11-01 | 2024-Q2 | R&D expenses % Q2 | 2.5% | 8 |
| 2023-11-01 | 2024-Q2 | R&D expenses % 6M prior year | 2.3% | 8 |
| 2023-11-01 | 2024-Q2 | R&D expenses % 6M | 2.5% | 8 |
| 2023-11-01 | 2024-Q2 | Gross profit margin Q2 prior year | 37.2% | 8 |
| 2023-11-01 | 2024-Q2 | Gross profit margin Q2 | 38.7% | 8 |
| 2023-11-01 | 2024-Q2 | Gross profit margin 6M prior year | 37.4% | 8 |
| 2023-11-01 | 2024-Q2 | Gross profit margin 6M | 37.8% | 8 |
| 2023-11-01 | 2024-Q2 | G&A expenses % Q2 prior year | 9.2% | 8 |
| 2023-11-01 | 2024-Q2 | G&A expenses % Q2 | 9.9% | 8 |
| 2023-11-01 | 2024-Q2 | G&A expenses % 6M prior year | 9.6% | 8 |
| 2023-11-01 | 2024-Q2 | G&A expenses % 6M | 10.8% | 8 |
| 2023-11-01 | 2024-Q2 | Cash and equivalents | $99,308,000 | 8 |
| 2023-11-01 | 2024-Q2 | Capex 6M prior year | $5,288,000 | 8 |
| 2023-11-01 | 2024-Q2 | Capex 6M | $10,319,000 | 8 |
| 2023-11-01 | 2024-Q2 | Working capital as a % of sales | 21.8% | 9 |
| 2023-11-01 | 2024-Q2 | Long-term backlog as % of total backlog | 46.7% | 9 |
| 2023-11-01 | 2024-Q2 | Long-term backlog | 148.3 (USD in millions) | 9 |
| 2023-11-01 | 2024-Q2 | Free cash flow | 11.7 (USD in millions) | 9 |
| 2023-11-01 | 2024-Q2 | Debt, net of cash, to net total capitalization | 35.3% | 9 |
| 2023-11-01 | 2024-Q2 | Debt to total capitalization percentage | 39.8% | 9 |
| 2023-11-01 | 2024-Q2 | Days sales outstanding | 58.6 | 9 |
| 2023-11-01 | 2024-Q2 | Backlog | 317.7 (USD in millions) | 9 |
| 2023-08-02 | 2024-Q1 | Working capital as a % of sales | 21.4% | 7 |
| 2023-08-02 | 2024-Q1 | Selling expenses as % of sales | 10.6% | 6 |
| 2023-08-02 | 2024-Q1 | Research and development expenses as % of sales | 2.5% | 6 |
| 2023-08-02 | 2024-Q1 | Orders | $257.0 million | 7 |
| 2023-08-02 | 2024-Q1 | Net debt leverage ratio | 2.9x | 7 |
| 2023-08-02 | 2024-Q1 | Long-term backlog as % of total backlog | 49.9% | 7 |
| 2023-08-02 | 2024-Q1 | Long-term backlog | 177.3 (USD millions) | 7 |
| 2023-08-02 | 2024-Q1 | Gross profit margin | 36.8% | 6 |
| 2023-08-02 | 2024-Q1 | General and administrative expenses as % of sales | 11.7% | 6 |
| 2023-08-02 | 2024-Q1 | Foreign subsidiaries cash | $84,822,000 | 6 |
| 2023-08-02 | 2024-Q1 | Debt, net of cash, to net total capitalization | 35.8% | 7 |
| 2023-08-02 | 2024-Q1 | Debt to total capitalization percentage | 40.6% | 7 |
| 2023-08-02 | 2024-Q1 | Days sales outstanding | 62.9 | 7 |
| 2023-08-02 | 2024-Q1 | Cash and cash equivalents | $107,244,000 | 6 |
| 2023-08-02 | 2024-Q1 | Book-to-bill ratio | 1.1x | 7 |
| 2023-08-02 | 2024-Q1 | Backlog | 355.3 (USD millions) | 7 |
Advertisement
Guidance Tracking (latest per metric/period · 11/27)#
All management forecasts (guidance) and their later outcome. Types: fiscal-year targets as well as quarterly/half-year targets; per metric and period the most recent statement applies, older versions can be expanded. The status is checked automatically against the actuals reported later: open (period still running), met, beaten, missed. For ranges (“X to Y”) reaching the range counts. Logged neutrally, no estimate of our own, no assessment.
Actuals: revenue in $m · EPS in $ per share
| For period | Guided on | Metric | Guided | Actual | Verdict | Direction | Source |
|---|---|---|---|---|---|---|---|
| FY2028 | 2026-02-09 | Net Leverage Ratio | 4 | – | pending | initiated | 29 |
| FY2027 | 2026-07-30 | Revenue | 2,090–2,150 | – | pending | raised | 33 |
| FY2027 | 2026-07-30 | EPS (non-GAAP) | 1.9–2.1 | – | pending | raised | 33 |
| FY2027 | 2026-07-30 | Capex | 50–60 | – | pending | initiated | 32 |
| FY2027 | 2026-07-30 | EBITDA (adjusted) | 405–420 | – | pending | raised | 33 |
| FY2026 | 2026-02-09 | Capex | 12–16 | – | – | – | 28 |
| FY2026 | 2025-10-30 | Revenue | Up low-to-mid single digits | 1,193.5 | – | raised | 26 |
| FY2026 | 2025-07-30 | EPS (non-GAAP) | Flat to slightly up | 1.87 | – | confirmed | 26 |
| 2026-Q4 | 2026-01-14 | Revenue | 250–260 | 437.8 | beat | initiated | 27 |
| 2026-Q4 | 2026-01-14 | EPS (non-GAAP) | 0.58–0.63 | 0.24 | miss | initiated | 27 |
| 2026-Q4 | 2026-01-14 | EBITDA (adjusted) | 38–40 | 68.7 | beat | initiated | 27 |
| FY2025 | 2025-02-10 | Capex | 18–22 | – | – | initiated | 18 |
| FY2025 | 2024-10-30 | Revenue | Flat to low-single digit growth year-over-year | 963 | – | confirmed | 17 |
| FY2025 | 2024-10-30 | EPS (non-GAAP) | Mid-single digit growth year-over-year | 2.48 | – | confirmed | 17 |
| FY2025 | 2024-10-30 | Net Leverage Ratio | ~2.3 | – | – | confirmed | 17 |
| 2025-Q3 | 2024-10-30 | Revenue | Flat year-over-year | 234.1 | – | confirmed | 17 |
| 2025-Q3 | 2024-10-30 | EPS (non-GAAP) | Flat year-over-year | 0.56 | – | confirmed | 17 |
| 2025-Q2 | 2024-07-31 | Revenue | Down low to mid-single digits year-over-year | 242.3 | – | cut | 15 |
| 2025-Q2 | 2024-07-31 | EPS (non-GAAP) | Down mid-single digits year-over-year | 0.7 | – | cut | 15 |
| 2025-Q1 | 2024-05-29 | Revenue | Low-single digit growth year-over-year | 239.7 | – | initiated | 13 |
| 2025-Q1 | 2024-05-29 | EPS (non-GAAP) | Flat to slightly down year-over-year | 0.62 | – | initiated | 13 |
| FY2024 | 2024-01-31 | Capex | 30–35 | – | – | initiated | 10 |
| FY2024 | 2023-11-01 | Tax rate | 24–26% | – | – | confirmed | 10 |
| 2024-Q4 | 2024-01-31 | Revenue | 260–270 | 265.5 | in line | confirmed | 11 |
| 2024-Q3 | 2023-11-01 | Revenue | 245–255 | 254.1 | in line | initiated | 9 |
| 2024-Q2 | 2023-08-02 | Revenue | 250–260 | 258.4 | in line | – | 7 |
| 2024-Q1 | 2023-05-25 | Revenue | 235–240 | 235.5 | in line | initiated | 5 |
Advertisement
Development#
A condensed summary per reporting period as running text: what changed operationally, which drivers management names, how earnings and cash flow developed. Most recent period first, grouped by year; each text is written from the original report of that period, superscript numbers lead to the source.
FY2027
In Q1 FY2027 (quarter ended June 2026), Columbus McKinnon Corp reported net sales of $531.5 million, an increase of 125.3% year-over-year, driven primarily by a $304.8 million contribution from the Kito Crosby acquisition completed February 3, 2026, along with $16.1 million in favorable volume and $2.4 million in foreign currency benefit, partially offset by a $34.8 million impact from divestitures (32). GAAP gross profit margin declined to 27.5% from 32.7%, reflecting $55.2 million of inventory step-up amortization expense attributable to acquisition accounting for Kito Crosby (32). Net income was a loss of $88.4 million, with interest and debt expense rising to $47.6 million from $8.7 million in the prior-year period as a result of borrowings to finance the $2.81 billion acquisition (32). On an adjusted basis, EBITDA reached $111.5 million with margin expansion of 720 basis points to 21.0%, and adjusted EPS increased 22% to $0.61, reflecting Kito Crosby accretion and early synergy realization (33). Following the Q1 result, full-year FY2027 guidance was raised across net sales, adjusted EBITDA, and adjusted EPS (33).
FY2026
Columbus McKinnon reported FY2026 net sales of $1,193.5 million, up 23.9% from $963.0 million in FY2025, with the $2.81 billion acquisition of Kito Crosby Limited – closed February 3, 2026 – contributing $188.1 million in revenue over approximately two months and expanding the company's global footprint to over 4,000 employees and 40 factories, while Legacy CMCO net sales grew approximately 7% driven by $21.5 million in price increases, $10.2 million in volume growth, and $24.6 million in favorable currency translation, partially offset by $14.0 million from divested operations 31. The company recorded a net loss of $229.5 million for FY2026, primarily reflecting a $200.0 million non-cash goodwill impairment charge for the Precision Conveyance reporting unit, $36.8 million in inventory step-up amortization from Kito Crosby, and $55.2 million in net deal and integration costs, partially offset by a $103.3 million gain on the divestiture of the U.S. power chain hoist business; adjusted EPS was $1.87 30 31. Gross margin compressed to 30.1% from 33.8% in FY2025, primarily due to inventory step-up amortization and $5.9 million in material inflation and tariff-related costs, while adjusted EBITDA reached $181.4 million at a 15.2% margin 31. To finance the Kito Crosby acquisition the company entered new credit facilities totaling $2.15 billion and issued $900.0 million in 7.125% Senior Secured Notes due 2033, alongside $780.98 million in Series A preferred shares issued to CD&R; at fiscal year-end the Credit Agreement Net Leverage Ratio stood at 5.1x with total liquidity of $561.2 million 31. The company issued fiscal 2027 guidance for net sales of $2.05–$2.12 billion, adjusted EBITDA of $390–$410 million, and adjusted EPS of $1.70–$1.90 30.
FY2025
Columbus McKinnon's fiscal 2025 net sales declined 5.0% to $963.0 million from $1,013.5 million in fiscal 2024, driven by lower sales volume of $60.2 million, partially offset by price increases of $12.5 million and the montratec acquisition contribution of $2.7 million 21. Gross profit margin fell to 33.8% from 37.0%, reflecting $6.9 million in Monterrey facility startup costs, $15.2 million in Charlotte and Precision Conveyance closure charges, and $33.0 million in volume-related profit decline 21. The company recorded a net loss of $5.1 million for fiscal 2025, inclusive of a $23.6 million non-cash pension settlement charge for the termination of one U.S. pension plan, $16.4 million in factory consolidation costs, and $12.8 million in Monterrey startup costs; adjusted EPS was $2.48 21, 22, 122. Columbus McKinnon repaid $60.7 million of debt during fiscal 2025 and reported record full-year orders of $1.0 billion, up 3%, with backlog growing 15% to $322.5 million at March 31, 2025 22. On February 10, 2025, the company announced a definitive agreement to acquire Kito Crosby Limited, expected to close during fiscal 2026 and funded through $3.05 billion in debt financing and $800 million in perpetual convertible preferred equity from Clayton, Dubilier & Rice 21.
FY2024
In fiscal 2024, Columbus McKinnon achieved record net sales of $1,013.5 million, up 8.3% year over year, driven by $33.8 million in pricing actions and $32.6 million in incremental revenue from the montratec GmbH acquisition completed May 31, 2023 12. Gross margin expanded 50 basis points to 37.0%, and Adjusted EBITDA grew 13% to $166.7 million with a margin of 16.4%, up 60 basis points 13. Net income for the year was $46.6 million, or $1.61 per diluted share, with adjusted EPS of $2.86 122. The company generated $67.2 million in operating cash flow and $42.4 million in free cash flow at 91% free cash flow conversion, while reducing its net leverage ratio to 2.4x by fiscal year-end 13. Precision conveyance was a standout growth driver throughout the year, with Q4 orders up 25%, and the company completed a manufacturing center of excellence in Mexico during Q3 11 13.
FY2023
Columbus McKinnon reported fiscal 2023 net sales of $936.2 million, a 3.3% increase year-over-year, driven by $47 million in pricing actions and $22.4 million in Garvey acquisition contribution, partially offset by a $9.2 million volume decrease and $30.6 million unfavorable foreign currency impact 4. Gross profit margin improved to 36.5% from 34.8%, reflecting net price increases over material inflation and a Garvey acquisition contribution of $9.5 million, partially offset by a $5 million productivity decrease 4. Operating income reached a record $97.8 million for the full year, with full-year adjusted EPS of $2.94 113. Operating cash flow increased to $83.6 million from $48.9 million in the prior year, with Q4 alone contributing $66.7 million, the strongest quarter on record 5. In April 2023, the company announced a definitive agreement to acquire montratec GmbH for approximately $110 million at closing plus an earnout not expected to exceed $14 million, extending its intelligent motion solutions platform 3.
Advertisement
Sources: official investor relations documents#
All original documents used, with type (e.g. quarterly, half-year, annual report), publication date and a direct link to the filing (EDINET/SEC/IR). Every superscript number in the report points to an entry in this list; so every figure can be traced back to its place in the original.
52 documents · 2016 – 2026 · SEC EDGAR (USA)
| # | Document type | Published | Link |
|---|---|---|---|
| #1 | 10-Q | 2023-02-01 | Open |
| #2 / #102 | 8-K-EX99.1 | 2023-02-01 | Open |
| #3 | 8-K-EX99.1 | 2023-04-26 | Open |
| #4 | 10-K | 2023-05-25 | Open |
| #5 / #105 | 8-K-EX99.1 | 2023-05-25 | Open |
| #6 | 10-Q | 2023-08-02 | Open |
| #7 / #107 | 8-K-EX99.1 | 2023-08-02 | Open |
| #8 | 10-Q | 2023-11-01 | Open |
| #9 / #109 | 8-K-EX99.1 | 2023-11-01 | Open |
| #10 | 10-Q | 2024-01-31 | Open |
| #11 / #111 | 8-K-EX99.1 | 2024-01-31 | Open |
| #12 | 10-K | 2024-05-29 | Open |
| #13 / #113 | 8-K-EX99.1 | 2024-05-29 | Open |
| #14 | 10-Q | 2024-07-31 | Open |
| #15 / #115 | 8-K-EX99.1 | 2024-07-31 | Open |
| #16 | 10-Q | 2024-10-30 | Open |
| #17 / #117 | 8-K-EX99.1 | 2024-10-30 | Open |
| #18 | 10-Q | 2025-02-10 | Open |
| #19 / #119 | 8-K-EX99.1 | 2025-02-10 | Open |
| #20 | 8-K-EX99.1 | 2025-02-12 | Open |
| #21 | 10-K | 2025-05-28 | Open |
| #22 / #122 | 8-K-EX99.1 | 2025-05-28 | Open |
| #23 | 10-Q | 2025-07-30 | Open |
| #24 / #124 | 8-K-EX99.1 | 2025-07-30 | Open |
| #25 | 10-Q | 2025-10-30 | Open |
| #26 / #126 | 8-K-EX99.1 | 2025-10-30 | Open |
| #27 | 8-K-EX99.1 | 2026-01-14 | Open |
| #28 | 10-Q | 2026-02-09 | Open |
| #29 / #129 | 8-K-EX99.1 | 2026-02-09 | Open |
| #30 / #130 | 8-K-EX99.1 | 2026-06-04 | Open |
| #31 | 10-K | 2026-06-08 | Open |
| #32 | 10-Q | 2026-07-30 | Open |
| #33 / #133 | 8-K-EX99.1 | 2026-07-30 | Open |
Older sources (+19)
| # | Document type | Published | Link |
|---|---|---|---|
| #201 | 10-K | 2016-06-01 | Open |
| #204 | 10-K | 2016-06-01 | Open |
| #202 | 10-Q | 2016-10-28 | Open |
| #207 | 10-K | 2017-05-31 | Open |
| #205 | 10-Q | 2017-08-01 | Open |
| #206 | 10-Q | 2017-10-31 | Open |
| #203 | 10-Q | 2018-02-06 | Open |
| #209 | 10-K | 2018-05-30 | Open |
| #208 | 10-Q | 2018-10-30 | Open |
| #213 | 10-K | 2019-05-29 | Open |
| #210 | 10-Q | 2019-07-30 | Open |
| #211 | 10-Q | 2019-11-07 | Open |
| #212 | 10-Q | 2020-02-04 | Open |
| #217 | 10-K | 2020-05-27 | Open |
| #214 | 10-Q | 2020-07-30 | Open |
| #215 | 10-Q | 2020-10-29 | Open |
| #216 | 10-Q | 2021-01-28 | Open |
| #218 | 10-Q | 2021-07-29 | Open |
| #219 | 10-Q | 2021-10-28 | Open |
FAQ#
Is there a management forecast (guidance) for FY2027?
Yes. Management has issued targets for FY2027, including Revenue. The guidance tracking chapter shows all targets and checks them against the actuals reported later; neutral, with no estimate of our own.
Does Columbus McKinnon Corporation pay a dividend?
The filings report on the dividend; most recent entry: dividend per share 0.07 (2026-Q1) (as reported, no assessment of our own). Details with source links are in the report chapters.
Where can I find the official investor relations documents of Columbus McKinnon Corporation?
The sources chapter links all 67 original filings used (SEC filings) with type, publication date and a direct link; every figure in the report carries a source number.
More reports#
Recently updated
Advertisement